tirzepatide first month First Month Weight Loss on

Because it affects gastric emptying, it can make it less effective

Step 2: Pull the pen cap straight off

Additional serious warnings from FDA prescribing information: severe gastrointestinal adverse reactions, acute kidney injury, acute gallbladder disease, acute pancreatitis, serious hypersensitivity reactions, hypoglycemia risk with insulin or insulin secretagogues, diabetic retinopathy and vision changes in patients with type 2 diabetes, depression or mood changes requiring clinical monitoring, and pulmonary aspiration risk during general anesthesia or deep sedation

Discontinuing tirzepatide typically results in gradual weight regain and potential worsening of glycemic control in patients with diabetes

offers medication-supported weight loss with consistent clinical monitoring and educational support